Abstract
This communication describes the synthesis of a new class of N-hydroxyguanidine (NHG) pro-drugs which release nitric oxide (NO), triggered by the action of ¿-glutamyl transpeptidase (¿-GT), and have potential for the treatment of acute renal injury/failure (ARI/ARF).
Original language | English |
---|---|
Pages (from-to) | 1389-1391 |
Number of pages | 3 |
Journal | Chemical Communications |
Volume | 49 |
Issue number | 14 |
DOIs | |
Publication status | Published - 18 Feb 2013 |
Keywords
- Acute Kidney Injury
- Guanidines
- Humans
- Nitric Oxide
- Prodrugs
- Vasodilator Agents
- gamma-Glutamyltransferase